Anebulo Pharmaceuticals, Inc. Liquidation Value Calculator
Anebulo Pharmaceuticals, Inc.
Current Price: N/A
Loading calculator data...
Advanced: All 57 XBRL Tags
Every XBRL tag from SEC EDGAR filings, grouped by financial statement type. total = may include children, fact = independent leaf value.
Balance Sheet
| Tag | Value | Unit | ||
|---|---|---|---|---|
| accounts_payable | ||||
| Accounts Payable Current total AccountsPayableCurrent |
$554,862 | USD | ||
| cash | ||||
| Cash And Cash Equivalents At Carrying Value total CashAndCashEquivalentsAtCarryingValue |
$9.04M | USD | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations total CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations |
$9.04M | USD | ||
| current_liabilities | ||||
| Accrued Liabilities Current total AccruedLiabilitiesCurrent |
$930,784 | USD | ||
| liabilities_total | ||||
| Liabilities total | $1.49M | USD | ||
| shares_outstanding | ||||
| Common Stock Shares Outstanding total CommonStockSharesOutstanding |
41.1M | shares | ||
Unmapped Tags (49)
| Additional Paid In Capital AdditionalPaidInCapital | $85.94M | USD | ||
| Assets Assets | $9.42M | USD | ||
| Assets Current AssetsCurrent | $9.27M | USD | ||
| Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare | $0 | USD/shares | ||
| Common Stock Shares Authorized CommonStockSharesAuthorized | $75.00M | shares | ||
| Common Stock Shares Issued CommonStockSharesIssued | $41.08M | shares | ||
| Common Stock Value CommonStockValue | $41,086 | USD | ||
| Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity | $9.42M | USD | ||
| Other Assets Noncurrent OtherAssetsNoncurrent | $148,231 | USD | ||
| Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare | $0 | USD/shares | ||
| Preferred Stock Shares Authorized PreferredStockSharesAuthorized | $2.00M | shares | ||
| Preferred Stock Shares Issued PreferredStockSharesIssued | $0 | shares | ||
| Preferred Stock Shares Outstanding PreferredStockSharesOutstanding | $0 | shares | ||
| Prepaid Insurance PrepaidInsurance | $60,700 | USD | ||
| Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit | $-78.05M | USD | ||
| Stockholders Equity StockholdersEquity | $7.94M | USD | ||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | $198,530 | USD | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | $-2.59M | USD | ||
| Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized | $1.30M | USD | ||
| Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable | $330,687 | USD | ||
| Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities | $667,271 | USD | ||
| Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense | $-86,026 | USD | ||
| Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities | $-2.59M | USD | ||
| Share Based Compensation ShareBasedCompensation | $436,174 | USD | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | $2.02M | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | $3 | USD/shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | $0 | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | $3.22M | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | $2 | USD/shares | ||
| Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | $5.48M | shares | ||
| Earnings Per Share Basic EarningsPerShareBasic | $-0 | USD/shares | ||
| Earnings Per Share Diluted EarningsPerShareDiluted | $-0 | USD/shares | ||
| General And Administrative Expense GeneralAndAdministrativeExpense | $2.91M | USD | ||
| Interest Expense InterestExpense | $35,000 | USD | ||
| Interest Expense Nonoperating InterestExpenseNonoperating | $34,878 | USD | ||
| Interest Income Other InterestIncomeOther | $195,026 | USD | ||
| Net Income Loss NetIncomeLoss | $-4.16M | USD | ||
| Nonoperating Income Expense NonoperatingIncomeExpense | $722,419 | USD | ||
| Operating Expenses OperatingExpenses | $4.88M | USD | ||
| Operating Income Loss OperatingIncomeLoss | $-4.88M | USD | ||
| Other Nonoperating Income Expense OtherNonoperatingIncomeExpense | $-130 | USD | ||
| Prepaid Expense Current PrepaidExpenseCurrent | $175,413 | USD | ||
| Research And Development Expense ResearchAndDevelopmentExpense | $1.97M | USD | ||
| Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent | $374,258 | USD | ||
| Accrued Professional Fees Current AccruedProfessionalFeesCurrent | $148,678 | USD | ||
| Amortization Of Financing Costs AmortizationOfFinancingCosts | $34,879 | USD | ||
| Entity Listing Par Value Per Share EntityListingParValuePerShare | $0 | USD/shares | ||
| Unamortized Loan Commitment And Origination Fees And Unamortized Discounts Or Premiums UnamortizedLoanCommitmentAndOriginationFeesAndUnamortizedDiscountsOrPremiums | $200,000 | USD | ||
| FeeIncome FeeIncome | $700,000 | USD |
Showing balance sheet tags only. Liquidation analysis uses balance sheet data.